Latest diabetic neuropathy Stories

2005-11-11 13:55:30

BOSTON "“ Foot ulcerations are one of the most serious complications of diabetes, resulting in more than 80,000 lower-leg amputations each year in the U.S. alone. A new study led by researchers at the Joslin-Beth Israel Deaconess Foot Center and Microcirculation Laboratory finds that early changes in the oxygenation of the skin could help foretell the development of ulcerations and enable doctors to treat patients at an earlier stage, before the onset of serious complications. Reported...

2005-09-29 22:00:56

ROCHESTER, Minn. -- Mayo Clinic researchers have found that subtle change in nerve conduction is the first reliable sign of nerve complications from diabetes and that this change can be measured long before other symptoms or signs of nerve damage develop. "We've found what we believe is the earliest sign of nerve change due to diabetes," says Peter J. Dyck, M.D., Mayo Clinic neurologist and lead researcher on the study. Results were published in the September issue of Diabetes Care. "Changes...

2005-08-17 10:20:22

By David Douglas NEW YORK (Reuters Health) - Individuals with diabetes often develop a problem with the nerves that control internal body functions, known as diabetic autonomic neuropathy. Autonomic neuropathy is a common and serious complication of diabetes, one that increases the risk of death. Effective treatments are limited by a lack of any clear understanding of what causes the problem. Now, European researchers report that so-called self or autoantibodies that attack the...

2005-08-02 09:19:54

NEW YORK (Reuters) - Eli Lilly and Co. on Tuesday said one of its experimental drugs proved effective against diabetic retinopathy, a sight-endangering complication of diabetes, but failed in late-stage trials against nerve damage caused by diabetes. Lilly shares were down 85 cents, or 1.5 percent, at $55.84, in morning trading on the New York Stock Exchange. The Indianapolis-based drugmaker said its ruboxistaurin medicine reduced vision loss in a trial among patients with diabetic...

2005-07-14 17:10:00

BOSTON "” July 14, 2005 "” A multicenter international study chaired by a Joslin Diabetes Center investigator and reported in the July issue of the American Diabetes Association's journal Diabetes brings hopeful news to the 18 million people in the United States "” and millions more worldwide "” with type 1 or type 2 diabetes. Initial results of the Phase III clinical trial demonstrated that 32 milligrams per day of ruboxistaurin (RBX) was well tolerated and may reduce...

Word of the Day
  • To talk saucily.
  • Insolent, opprobrious language; impertinent abuse.
This word is Scots in origin and probably imitative.